Josep M. Llovet, MD

Josep M. Llovet, MD, Mount Sinai

Articles by Josep M. Llovet, MD

Josep M. Llovet, MDGI Cancer | March 13, 2025
Dr. Josep Llovet discusses promising data, including higher PFS and OS, in metastatic liver cancer from the LEAP-012 trial.
View More
Josep M. Llovet, MDHepatocellular Carcinoma | March 13, 2025
Drs. Llovet and Finn consider how LEAP-002 adds to the debate around IO/VEGF, IO/IO, and IO/TKI for aHCC.
Josep M. Llovet, MDHepatocellular Carcinoma | March 13, 2025
Drs. Llovet and Finn provide a high-level understanding of LEAP-002, looking at lenvatinib/pembrolizumab for 1L aHCC.